계명대학교 의학도서관 Repository

A Prospective Phase 2 Multicenter Study for the Efficacy of Radiation Therapy Following Incomplete Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma

Metadata Downloads
Affiliated Author(s)
김진희
Alternative Author(s)
Kim, Jin Hee
Journal Title
International Journal of Radiation Oncology*Biology*Physics
ISSN
0360-3016
Issued Date
2014
Abstract
Purpose: The purpose of this study was to investigate the efficacy and toxicity of
radiation therapy (RT) following incomplete transarterial chemoembolization (TACE)
in unresectable hepatocellular carcinoma (HCC).
Methods and Materials: The study was designed as a prospective phase 2 multicenter
trial. Patients with unresectable HCC, who had viable tumor after TACE of no more
than 3 courses, were eligible. Three-dimensional conformal RT (3D-CRT) was added
for HCC treatment with incomplete uptake of iodized oil, and the interval from TACE
to RT was 4 to 6 weeks. The primary endpoint of this study was the tumor response
after RT following incomplete TACE in unresectable HCC. Secondary endpoints were
patterns of failure, progression-free survival (PFS), time to tumor progression (TTP),
overall survival (OS) rates at 2 years, and treatment-associated toxicity. Survival was
calculated from the start of RT.Results: Between August 2008 and December 2010, 31 patients were enrolled. RT
was delivered at a median dose of 54 Gy (range, 46-59.4 Gy) at 1.8 to 2 Gy per fraction.
A best objective in-field response rate was achieved in 83.9% of patients, with
complete response (CR) in 22.6% of patients and partial response in 61.3% of patients
within 12 weeks post-RT. A best objective overall response rate was achieved in 64.5%
of patients with CR in 19.4% of patients and PR in 45.1% of patients. The 2-year
in-field PFS, PFS, TTP, and OS rates were 45.2%, 29.0%, 36.6%, and 61.3%, respectively.
The Barcelona Clinic liver cancer stage was a significant independent prognostic
factor for PFS (PZ.023). Classic radiation-induced liver disease was not
observed. There were no treatment-related deaths or hepatic failure.
Conclusions: Early 3D-CRT following incomplete TACE is a safe and practical treatment
option for patients with unresectable HCC. 2014 Elsevier Inc.
Department
Dept. of Radiation Oncology (방사선종양학)
Publisher
School of Medicine
Citation
Chihwan Choi et al. (2014). A Prospective Phase 2 Multicenter Study for
the Efficacy of Radiation Therapy Following
Incomplete Transarterial Chemoembolization
in Unresectable Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 90(5), 1051–1060. doi: 10.1016/j.ijrobp.2014.08.011
Type
Article
ISSN
0360-3016
DOI
10.1016/j.ijrobp.2014.08.011
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/34818
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학)
Authorize & License
  • Authorize공개
  • EmbargoForever
Files in This Item:

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.